Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNA

C. Mareso, Maria Luigia Crosta, M. G. De Vita, F. Cristofoli, B. Tanzi, S. Benedetti, G. Bonetti, C. A. Donofrio, M. Cominetti, L. Riccio, A. Fioravanti, Daniele Generali, Emanuela Lucci Cordisco, Pietro Chiurazzi, V. Gatta, L. Stuppia, S. Cecchin, M. Bertelli, G. Marceddu

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Background: Liquid biopsy is considered a complementary and recently also an alternative method to surgical biopsy. It allows for the acquisition of valuable information regarding the potential presence of tumors, particularly through the analysis of circulating tumor DNA (ctDNA). CtDNA is a fraction of circulating free DNA (cfDNA) that can be extracted from various tissues, with blood being the most readily available. Results: To maximize the yield of plasma separation, specific Streck tubes are recommended for blood collection. The MagPurix CFC DNA Extraction Kit can be used for cfDNA extraction, and the TWIST Library Preparation protocol can be optimized for further analysis. Next-generation sequencing (NGS) can be employed to compare somatic and germline lineages, enabling the identification of somatic variants with a Variant Allele Frequency (VAF) of 5 % or higher, which are absent in the germline lineage. Conclusion: This analysis helps in the assessment of recurrence, analysis, and monitoring of cancer tissue.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaGene
Volume928
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • Cancer
  • cfDNA
  • NGS
  • Liquid biopsy
  • ctDNA

Fingerprint

Entra nei temi di ricerca di 'Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNA'. Insieme formano una fingerprint unica.

Cita questo